Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Sep 24, 2014
Watch as Dr. Owen O’Connor gives us an overview of the state of treatment for T-Cell lymphoma and the latest news on emerging therapies. Despite a historical challenge in treating T-cell lymphomas, Dr. O’Connor is encouraged by the recent drug approvals and ongoing clinical trials into the use of histone deacetylase (HDAC) inhibitors both as single agents and in combinations with chemotherapies.